Back to search

Norway· NO-ID_B7BD48A2-2081-471A-9B2A-5C54F50E37CD

Nycoplus Ferro-Retard

A ferrous sulfate product containing ferrous sulfate, registered in Norway by Orifarm Healthcare A/S. The same ATC class is registered in 10 of our 19 countries.

ATC B03AA07

Checked against FEST (Norway) on

Informational only — not a medical device.

SOURCE REGISTER · NOFEST (Norway)normalisedNycoplus Ferro-RetardATCB03AA07REGISTER NO.NO-ID_B7BD48A2-2081-4…PACKS LISTED5CHECKEDOctober 2, 2026

Where it is registered

Ferrous sulfate is registered in 10 of 19 countries.

Countries holding a registration under ATC B03AA07 (ferrous sulfate), each read from that country’s own register.

  • This record: Norway, from FEST (Norway)
  • 7 of them publish a price we can compare per daily dose

Ferrous sulfate · ATC B03AA07

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of ferrous sulfate costs, country by country.

Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Ferrous sulfate · price per daily dose (0.2 g)

USD · FX 28 Sept 2026

  • CH Switzerland$0.77
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

FEST (Norway)
Active substance
Ferrous Sulfate
Manufacturer
Orifarm Healthcare A/S
Country
Norway (NO)
ATC code
B03AA07
ATC class
Ferrous sulfate
Defined daily dose
0.2 g, O
Reimbursed
Not published by this register
Source register
FEST (Norway)
Last checked
October 2, 2026

Packs & prices · 5

  • gtin
    7046265955207
  • gtin
    7046261255677
  • no_merkevare_id
    ID_B7BD48A2-2081-471A-9B2A-5C54F50E37CD
  • no_varenummer
    595520
    100
  • no_varenummer
    125567
    5 x 200

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

80 interactions on record for ferrous sulfate.

Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Ferrous sulfate · interactions on record

80 records

  • 3 severe
  • 68 moderate
  • 7 minor

Most severe, free to view

  • DolutegravirJ05AJ03severe
  • DolutegravirJ05AX12severe
  • DimercaprolV03AB09severe
  • Magnesium carbonateA02AA01moderate

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Ferrous sulfate in 12 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All ferrous sulfate products

Authorised across Europe · EMA

The same active substance is authorised in 12 EEA countries. Names it is sold under:

  • Austria · Ferro - Gradumet
  • Belgium · Fero-Gradumet
  • Germany · Eisensulfat Lomapharm, Ferro Aiwa
  • Spain · Ferogradumet
  • France · Fer Nouveau-Ne Ap-Hp
  • United Kingdom (Northern Ireland) · Feospan, Ferrous Sulfate Wockhardt Uk
  • Greece · Tardyferon
  • Hungary · Ferro-Gradumet
  • Lithuania · Tardyferon
  • Luxembourg · Fero-Gradumet
  • Portugal · Ferro-Gradumet
  • Slovakia · Tardyferon

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FEST (Norway). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/02172f8f-d7c0-4d2f-bf78-cd39fcd240f1
GET /v1/drugs/02172f8f-d7c0-4d2f-bf78-cd39fcd240f1?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Depottablett",
  "source": "fest",
  "status": "A",
  "atc_name": "Jern(II)sulfat",
  "merkevare_id": "ID_B7BD48A2-2081-471A-9B2A-5C54F50E37CD",
  "name_form_strength": "Nycoplus Ferro-Retard depottab 100 mg",
  "prescription_group": "F"
}

See everything about ferrous sulfate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.